started · updated
Danish C25 index rises as ISS and Genmab lead gains
The Danish C25 index closed up 0.82 percent on Monday, November 9, reaching 2,025.43. This brings the index's year-to-date increase to 11.04 percent.
Key movers included ISS A/S, which rose 4.11 percent to 309.20 DKK, and Genmab, which saw a 3.80 percent increase. In contrast, Coloplast fell 2.26 percent and A. P. Møller-Mærsk declined by 2.14 percent. Novo Nordisk remained the most heavily traded stock with a turnover of approximately 1.1 billion DKK.
In separate market activity, Genmab reported third-quarter revenue growth of 16 percent to 1.187 billion USD, meeting consensus expectations, while operating profit of 431 million USD exceeded forecasts due to lower operating costs. Despite these results, the stock experienced volatility following its strong yearly performance.
Entities
C25 Index · Denmark · Genmab · ISS A/S · Novo Nordisk